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Abstract
BACKGROUND: Adenotonsillar hypertrophy is a common disorder in the children’s population that can lead to 
growth disorders. Chronic adenotonsillar hypertrophy can cause a break in the normal growth of children, weight 
loss, and decreased growth hormone secretion. 
AIM: The purpose of this study was to evaluate adenotonsillar hypertrophy in the growth rate of children with height, 
weight, and body mass index (BMI).
METHODS: In this descriptive-analytical cross-sectional study, after examining 312, 3–10-year-old children with 
adenotonsillar hypertrophy, who met the inclusion criteria, growth scales were evaluated and entered into the patient 
evaluation form.
RESULTS: There was a significant relationship between BMI, height, weight, and severity of tonsillar hypertrophy 
at Brodsky’s scale (P <0.001). Our studies showed well that with increasing severity of adenotonsillar hypertrophy 
disease, the growth indicators are also decreased in children.
CONCLUSION: Adenotonsillar hypertrophy decreases growth indicators in children. There was also a relationship 
between growth indicators and severity of adenotonsillar hypertrophy in patients.
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Introduction
Adenotonsillar hypertrophy is a common 
disorder in the children population that causes an 
obstruction in the nasal route and eustachian tube and 
prevents drainage of nasal mucus [1]. The common 
clinical signs of adenotonsillar hypertrophy include 
nasal congestion, which results in sleep disorders from 
snoring to obstructive sleep apnea, rhinorrhea, oral 
respiration, hyponasal speech, and cough [2].
Obstructive sleep apnea, as one of the most 
damaging disorders of adenotonsillar hypertrophy, leads to 
frequent hypoxia and sleep disturbances, which can have 
adverse effects on the cognitive and behavioral nervous 
evolution of children as well as cardiovascular disorders. 
Another disorder that patients with adenotonsillar 
hypertrophy and airway obstruction may encounter 
is developmental disorders. Chronic adenotonsillar 
hypertrophy and subsequent upper airway obstruction 
appear to cause a disruption in the normal growth of 
children [3], [4], [5] and weight loss [6]. Several studies 
have also indicated that adenotonsillar hypertrophy and its 
subsequent sleep apnea are along with slow growth and 
weight gain in infants and babies [7], [8], [9]. These disorders 
are due to a number of factors such as decreased growth 
hormone secretion in the sleep phase, decreased insulin-
like growth factor 1 (IGF-I) [3], [10], as well as decreased 
energy intake due to difficulty swallowing and increased 
energy consumption during the sleep [11].
Due to the importance of the proper growth and 
weighting process in children and its close relationship 
to children’s health, responsible health systems, 
especially in developed countries are spending large 
amounts of money on monitoring and controlling this 
process in children to identify and resolve the factors 
that have a negative impact on that [12].
The purpose of this study was to investigate 
the relationship between body mass index (BMI) and 
adenotonsillar hypertrophy in children.
Materials and Methods
The study population
In this study, all referral children with 
adenotonsillar hypertrophy to the clinics of 
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Khatamolanbia Hospital during the 2017–2018 were 
evaluated. Inclusion criteria were adenotonsillar 
hypertrophy, 3–10 years old, and patient satisfaction, 
and no history of any other concomitant disease to 
participate in the study.
Procedure
This study was a descriptive-analytical 
observational study and included 312 children with 
the age of 3–10 years with adenotonsillar hypertrophy, 
whose parents were consenting to participate in the 
study. Age and sex information were collected by asking 
from parents. The intensity of tonsillar hypertrophy was 
determined based on Brodsky’s scale, where; zero: 
Tonsil did not affect airway; +1 intensity: Affect the 
airway <25%; +2 intensity: Affect the airway between 
25 and 50%; +3 intensity: Affect the airway between 
50-75%, and + 4 intensity: Affect the airway over 75%. 
In addition, the weight of these children with lightweight 
clothing without shoes was measured by a pointer scale 
with a measuring error of 100 g, and their height without 
shoes was also measured with a 5 mm accuracy height 
meter.
Statistical analysis
The obtained information was recorded in data 
collection forms. After completing the sampling, data 
were analyzed in SPSS software version 22.
Results
BMI
The mean BMI was (85/87±38/43) in the 
evaluation of patients based on BMI percentile, which 
among them, the mean BMI for boys was calculated 
(37/38±42/34) and for girls (01/30±13/66). There was 
no significant relationship between BMI percentile and 
age of patients (p < 0.151), but there was a significant 
relationship between this variable and sex (p < 0.001).
Statistical analysis also showed a significant 
difference between the severity of adenotonsillar 
hypertrophy (Brodsky’s scale) and BMI (p < 0.001). 
It should be noted that the correlation between the 
severity of adenotonsillar hypertrophy and BMI was 
R = −0.69, which indicating a moderate and inverse 
correlation. Table 1 summarizes the results of statistical 
analyzes on BMI.
Height growth
The calculated relationship between age and 
height growth showed that with increasing age, the 
mean height also shows an increasing and significant 
correlation between age and height of people (p < 0.001) 
and strong and direct correlation (R = 0.96).
Further reviews on height showed that the mean 
height in males was (83/16±47/113) and in females was 
(48/15±55/106), and there was a significant relationship 
between sex and height of patients (p < 0.002).
There was no significant relationship between 
height index and intensity of Tonsillar hypertrophy 
based on Brodsky’s scale (p = 0.07) and there was a 
positive and weak correlation between these two criteria 
(R = 0.21). In Table 2 was showed the relationship 
between age, sex, and severity of adenotonsillar 
hypertrophy with height growth.
Weight: Similar to the relationship between 
age and height, there was a significant relationship 
between age and weight of participants (p < 0.001) and 
the correlation between them (R = 0.88) indicated a 
strong and direction relationship.
Table 1: Impact of age, gender, and severity of adenotonsillar 
hypertrophy on BMI (by percentile) of children with 
adenotonsillar hypertrophy, who referred to Khatamolanbia 
Hospital during 2017–2018
Variable Mean BMI by percentile Standard deviation Value of p
Age (year)
3 45/59 44/20 p<0/151
4 71/07 28/87
5 39/70 0
6 27/56 35/64
7 0/36 0/25
8 3/6 0
9 4 0
10 68/94 25/72
Sex
Male 34/42 38/37 p<0/001<
Female 66/13 30/01
Adenotonsillar hypertrophy by Brodsky scale
0 18/60 2/17 p<0/001
1 20/08 3/48
2 15/38 1/14
3 14/30 1/45
4 14/11 32/35
Total 43/87 38/85
BMI: Body mass index.
Table 2: Impact of age, gender, and severity of adenotonsillar 
hypertrophy on the height growth process of children with 
adenotonsillar hypertrophy, who referred to Khatamolanbia 
Hospital during 2017–2018
Variable Mean height Standard deviation Value of p
Age (year)
3 90/23 2/10 p<0/001
4 97/23 4/55
5 106 0
6 107/42 2/47
7 114/93 1/01
8 124 0
9 126 0
10 130/51 10/12
Sex
Male 113/47 16/83 p<0/002
Female 106/55 15/48
Adenotonsillar hypertrophy by Brodsky scale
0 109/87 24/27 p<0/07
1 109/05 21/82
2 114/86 11/70
3 112/29 12/68
4 110/77 13/46
Total 111/41 16/72
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The calculated weighted mean in males was 
(54/10±51/21) and (86/5±69/19) in females. There was 
no significant relationship between sex and weight of 
patients (p = 0.34) (Table 3). Calculations showed that 
weight and intensity of Tonsillar hypertrophy based 
on Brodsky’s scale a significant relationship between 
inverse and mean correlation (p < 0.001) (R = 0.22).
Discussion
The nose and oral area has a growing 
lymphoid tissue [13]. Tonsillar hypertrophy is the most 
common cause of laryngeal obstruction and sleep-
related respiratory disorders. Obstructive sleep apnea 
is a common disease in children with adenotonsillar 
hypertrophy syndrome. Some of the factors caused by 
adenotonsillar hypertrophy including too loud snoring, 
chronic oral breathing, frequent waking at night, 
excessive drowsiness, nightmares, poor educational 
performance, and dysphagia. Children with obstruction 
caused by tonsillar hypertrophy usually eat less 
and have a lower weight percentage due to loss of 
appetite [13].
Among the 312 studied patients, 70.2% were 
male and 29.8% were female. Obviously, in different 
studies, the proportion of these communities is also 
different [12], [14], [15], and the reason for this difference 
is the sampling in different study communities, the 
population under study, and the male and female 
populations of different geographic areas. As noted in 
the findings section, sex was significantly associated 
with BMI percentile and height. However, there was no 
relationship between sex and weight of patients. The 
reason for this can be attributed to the heterogeneity of 
male and female populations in this study.
The relationship between age and 
adenotonsillar hypertrophy is somehow that most 
studies have been stated that age before 15 is the age 
of diagnosis. The mean age of the study population was 
(6/2±53/72) and statistical analysis showed a significant 
relationship between age and weight and height growth 
so that the correlation between age and these two 
variables showed their direct and strong relationship, 
and in both male and female, by weight increasing 
and despite adenotonsillar hypertrophy, the height and 
weight of the child also increase.
In evaluating the relationship of adenotonsillar 
hypertrophy with BMI, it was found that BMI in growth 
percentiles was very low in 40.1% of patients, and 
also 40.4% had proportional weight to age, while 5.1% 
was overweight, and 14.4% had too much weight 
(obese). In previous studies, BMI percentiles below 
2 were malnourished, between 2 and below 91 were 
normal, and above 91 considered obese, whereas in 
our study, based on the latest reference changes, the 
percentiles below 5% were low weight, 50% to 85% 
were proportional, and 85% to 95% were overweight 
and above 95% were obese [16].
Our study indicated that a large population of 
people with adenotonsillar hypertrophy did not have 
adequate weight gain. The cause of this can be traced to 
the effect of adenotonsillar hypertrophy on metabolism. 
In the Lumeng and Herrmann experiments, it has been 
demonstrated that chronic adenotonsillar hypertrophy can 
increase calorie intake and energy loss and consequently 
impair the development of children [17], [18].
The mean height of 312 patients in our study 
was 111 cm by percentile (41/21±54/16). About 29.8% 
of patients had short height, 65.1% moderate height, 
and 5.1% taller than normal. The mean weight of 
children in this study was 20 kg which was calculated 
(19/33±32/27) by percentile. This data indicate growth 
delay in the studied groups in terms of BMI and height 
and weight. Thus, it can be observed that, are consistent 
with other studies, chronic adenotonsillar hypertrophy 
can impair the normal growth process [8], [19].
It has been proven today that obstructive apnea 
caused by adenotonsillar hypertrophy, decreases the 
secretion of growth hormone IGF [20].
IGF-1 is a growth factor that has endocrine 
and paracrine effects and its secretion is controlled by 
growth hormone. Most of the existing IGF-1 carries the 
bond protein that it is called IGF binding protein-3 (IGF 
BP3).
IGF BP3 synthesis is also controlled by growth 
hormone. Levels of IGF-1 are applied, so serum levels 
of IGF BP3 and IGF-1 are considered to evaluate 
growth hormone levels [8].
Park tests showed that after adenotonsillar 
surgery, the serum IGF1 levels [21] and height were 
increased, and the increasing of weight is obvious [15].
In addition to the effect of adenotonsillar 
hypertrophy on the growth IGF-1 hormone secretion, 
Table 3: Impact of age, gender, and severity of adenotonsillar 
hypertrophy on the weight rate of children with adenotonsillar 
hypertrophy, who referred to Khatamolanbia Hospital during 
2017–2018
Variable Mean weight Standard deviation Value of p
Age (year)
3 13/36 1/99 p<0/001
4 16 0
5 17 0
6 16/95 0/82
7 15/6 1/52
8 21 0
9 22 0
10 33 9/18
Sex
Male 21/51 10/54 p=0/34
Female 19/69 5/86
Adenotonsillar hypertrophy by Brodsky scale
0 24/21 13/16 p<0/001
1 25/66 13/53
2 20/67 5/25
3 18/44 4/95
4 17/65 5/63
Total 20/97 9/42
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it seems that it can provide a suitable substrate for 
the growth of pathogenic bacteria, especially beta-
lactamase-producing groups in tonsillar and adenoid 
tissue. Growth of bacteria along with obstructive apnea 
in chronic adenotonsillar hypertrophy can increase 
metabolism and calorie consumption and subsequently 
impaired child development [17], [18].
In the reviews of 61 adenotonsillectomized 
children and comparing them with other 31 healthy 
children found that troubleshooting such as sleep 
apnea, nocturnal hypoxia, and sleep disorders, with 
adenotonsillar surgery, led to an increase in all children.
In the study of growth phenomena and its 
chemical markers [22], [23] in children with obstructive 
sleep apnea due to adenotonsillar hypertrophy, 70 
children were studied as patients and 35 children as 
a control group for IGF BP3 and IGF-1. This study 
showed that during the post-operative phase, the ratio 
of weight to height and secretion of IGF-1 and IGF-BP3 
increased [24].
Conclusion
In this study, we observed a decrease in growth 
indicators in children with adenotonsillar hypertrophy 
(height, weight, and BMI). Furthermore, there was a 
relationship between growth indicators and severity of 
adenotonsillar hypertrophy in patients.
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